Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes

Journal of Endocrinology

Volumn 209, Issue 2, 2011, Pages 185-191

  Lin, Yi ^a   Sun, Zhongjie ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN; INSULIN; LIOTHYRONINE; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG DOSE INCREASE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINARY EXCRETION;

ALBUMINURIA; ANIMALS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HYPERGLYCEMIA; KIDNEY CORTEX; MALE; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; TRANSFORMING GROWTH FACTOR BETA1; TRIIODOTHYRONINE;

EID: 79955546978     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0340     Document Type: Article

References (28)

1. Breyer MD, Bottinger E, Brosius FC III, Coffman TM, Harris RC, Heilig CW& Sharma K 2005 Mouse models of diabetic nephropathy. Journal of the American Society of Nephrology 16 27-45. (doi:10.1681/ASN.2004080648).
2. Brosius FC III 2008 New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Reviews in Endocrine and Metabolic Disorders 9 245-254. (doi:10.1007/s11154-008-9100-6).
3. Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL & Lin HD 2007 Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients. Diabetic Medicine 24 1336-1344. (doi:10.1111/j.1464-5491.2007.02270.x).
4. Chiarelli F, Gaspari S & Marcovecchio ML 2009 Role of growth factors in diabetic kidney disease. Hormone and Metabolic Research 41 585-593. (doi:10.1055/s-0029-1220752).
5. Cohen MP, Lautenslager GT & Shearman CW 2001 Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice. Metabolism: Clinical and Experimental 50 1435-1440. (doi:10.1053/meta.2001.28074).
6. Feliers D, Duraisamy S, Faulkner JL, Duch J, Lee AV, Abboud HE, Choudhury GG & Kasinath BS 2001 Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney International 60 495-504. (doi:10.1046/j.1523-1755.2001.060002495.x).
7. den Hollander JG, Wulkan RW, Mantel MJ & Berghout A 2005 Correlation between severity of thyroid dysfunction and renal function. Clinical Endocrinology 62 423-427. (doi:10.1111/j.1365-2265.2005.02236.x).
8. Iglesias P & Diez JJ 2009 Thyroid dysfunction and kidney disease. European Journal of Endocrinology/European Federation of Endocrine Societies 160 503-515. (doi:10.1530/EJE-08-0837).
9. Islam S, Yesmine S, Khan SA, Alam NH & Islam S 2008 A comparative study of thyroid hormone levels in diabetic and non-diabetic patients. Southeast Asian Journal of Tropical Medicine and Public Health 39 913-916.
10. Kaplan MM & Young JB 1987 Abnormal thyroid hormone deiodination in tissues of ob/ob and db/db obese mice. Endocrinology 120 886-893. (doi:10.1210/endo-120-3-886)
11. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK et al. 2000 Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB Journal 14 439-447.
12. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R & Haneda M 2003 Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. Journal of the American Society of Nephrology 14 S250-S253. (doi:10.1210/endo-120-3-886).
13. Kumar D, Robertson S & Burns KD 2004 Evidence of apoptosis in human diabetic kidney. Molecular and Cellular Biochemistry 259 67-70. (doi:10.1023/B:MCBI.0000021346.03260.7e)
14. Lehmann R & Schleicher ED 2000 Molecular mechanism of diabetic nephropathy. Clinica Chimica Acta 297 135-144. (doi:10.1016/S0009-8981(00)00240-0)
15. Lin Y & Sun Z 2010a Current views on type 2 diabetes. Journal of Endocrinology 204 1-11. (doi:10.1677/JOE-09-0260).
16. Lin Y & Sun Z 2010b Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. British Journal of Pharmacology 162 597-610. (doi:10.1111/j.1476-5381.2010.01056.x)
17. Price PM 2007 Diabetes: caught in the Akt? Kidney International 71 839-841. (doi:10.1038/sj.ki.5002200).
18. Rane MJ, Song Y, Jin S, Barati MT,Wu R, Kausar H, Tan Y,Wang Y, Zhou G, Klein JB et al. 2010 Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. American Journal of Physiology. Renal Physiology 298 F49-F61. (doi:10.1152/ajprenal.00032.2009).
19. Ruggenenti P & Remuzzi G 1998 Nephropathy of type-2 diabetes mellitus. Journal of the American Society of Nephrology 9 2157-2169.
20. Sharma K, McCue P & Dunn SR 2003 Diabetic kidney disease in the db/db mouse. American Journal of Physiology. Renal Physiology 284 F1138-F1144. (doi:10.1152/ajprenal.00315.2002)
21. Singer MA 2001 Of mice and men and elephants: metabolic rate sets glomerular filtration rate. American Journal of Kidney Diseases 37 164-178. (doi:10.1016/S0272-6386(01)80073-1).
22. Steffes MW, Osterby R, Chavers B &Mauer SM 1989 Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38 1077-1081. (doi:10.2337/diabetes.38.9.1077).
23. Suher M, Koc E, Ata N & Ensari C 2005 Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Renal Failure 27 739-742. (doi:10.1080/08860220500243338).
24. Suzuki D & Miyata T 1999 Carbonyl stress in the pathogenesis of diabetic nephropathy. Internal Medicine 38 309-314. (doi:10.2169/internalmedicine.38.309).
25. Tejada T, Catanuto P, Ijaz A, Santos JV, Xia X, Sanchez P, Sanabria N, Lenz O, Elliot SJ & Fornoni A 2008 Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney International 73 1385-1393. (doi:10.1038/ki.2008.109).
26. van Welsem ME & Lobatto S 2007 Treatment of severe hypothyroidism in a patient with progressive renal failure leads to significant improvement of renal function. Clinical Nephrology 67 391-393.
27. Zhu Y, Usui HK & Sharma K 2007 Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Seminars in Nephrology 27 153-160. (doi:10.1016/j.semnephrol.2007.01.008).
28. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA & Sharma K 2000 Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. PNAS 97 8015-8020. (doi:10.1073/pnas.120055097).